Iodide

Iodide

SCHEMBL238393

C[N+](C)(C)c1ccccc1.[I-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 6/20 0.46
APOBEC3A P31941 1/20 1.00
APOBEC3G Q9HC16 1/20 1.00
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37
CHRNB2 P17787 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
BCHE P06276 1/20 0.32
SCN1A P35498 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL11871441 1.00 APOBEC3A (1.00) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
Hydrochloric Acid SCHEMBL3871330 0.97 APOBEC3A (0.94) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
Water SCHEMBL3641332 0.97 APOBEC3A (0.94) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
Iodide SCHEMBL11871445 0.97 APOBEC3A (0.94) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
SCHEMBL12020269 0.97 APOBEC3A (0.93) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
SCHEMBL147815 0.97 APOBEC3A (0.93) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
Iodide SCHEMBL27556753 0.94 APOBEC3A (0.88) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
SCHEMBL7546898 0.93 APOBEC3A (0.88) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
Water SCHEMBL35582 0.93 APOBEC3A (0.88) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E
Bromide SCHEMBL238552 0.93 APOBEC3A (0.88) APOBEC3AAPOBEC3GACHEALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 702 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260140444-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-05-21 US claimed
CN-115819320-B Synthesis method of spirotetramat 江西汇和化工有限公司 2024-12-20 CN claimed
CN-118207630-A Bismuth-based perovskite single crystal, preparation method thereof, semiconductor material and X-ray detector 华中科技大学鄂州工业技术研究院 2024-06-18 CN claimed
CN-116444410-A Bridged ring compound and preparation method thereof 中国科学院上海有机化学研究所 2023-07-18 CN claimed
CN-116288166-A Preparation method of three-source co-evaporated inorganic perovskite thin film and solar cell 华中科技大学 2023-06-23 CN claimed
CN-115850181-A Method for synthesizing prochloraz 江西汇和化工有限公司 2023-03-28 CN claimed
CN-115819320-A Synthesis method of spirotetramat 江西汇和化工有限公司 2023-03-21 CN claimed
CN-115241384-A Formamidine lead-based perovskite material as well as preparation method and application thereof 南京邮电大学 2022-10-25 CN claimed
CN-113087625-B Method for synthesizing benzyl acetate by utilizing combined catalytic system 潜江新亿宏有机化工有限公司 2022-04-01 CN claimed
CN-113307728-B Preparation method of populus canula pheromone 南京蕃茂生物科技有限公司 2022-02-11 CN claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
EP-0615857-A1 Recording sheets containing monoammonium compounds XEROX CORPORATION (US) 1994-09-21 EP claimed
US-5320902-A Suitable for use in ink jet printing XEROX CORPORATION (US) 1994-06-14 US claimed
EP-0331052-A2 Process for the preparation of imidized acrylic polymers ELF ATOCHEM ITALIA S.r.l. (IT) 1989-09-06 EP claimed
EP-0012819-B1 METHOD FOR FORMING A FILM ADHERING TO A SUBSTRATE AND METHOD FOR WRITING AND ERASING INFORMATION IN A FILM THUS PREPARED International Business Machines Corporation (US) 1985-06-12 EP claimed
EP-0020974-B1 ELECTROCHROMIC PRINTING INK DISSOLVED IN WATER AND METHOD FOR PRINTING WITH THIS PRINTING INK International Business Machines Corporation (US) 1984-02-08 EP claimed
US-4211616-A Electrochromic printing system INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1980-07-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260140444-A1 PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE INO80C, INO80, NAT10 ACHE 3949/4885APOBEC3A 349/4885APOBEC3G 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.